K. Balampanis

发表

Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow–Up Study

J. Lekakis, G. Dimitriadis, I. Andreadou, 2019, Journal of clinical medicine.

SRC-3/AIB-1 Enhances Hepatic NFATC1 Transcription and Mediates Inflammation in a Tissue-Specific Manner in Morbid Obesity.

G. Lambrou, V. Lambadiari, Athina Chasapi, 2019, Endocrine, metabolic & immune disorders drug targets.

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment

G. Dimitriadis, I. Andreadou, E. Iliodromitis, 2020, Journal of the American Heart Association.

Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes

G. Dimitriadis, I. Andreadou, J. Parissis, 2021, Antioxidants.

The Effects of Different Hormones on Supraventricular and Ventricular Premature Contractions in Healthy Premenopausal Women

V. Lambadiari, I. Ikonomidis, Savvas Loizos, 2021, Medicina.

Inter-tissue expression patterns of the key metabolic biomarker PGC-1α in severely obese individuals: Implication in obesity-induced disease.

G. Dimitriadis, G. Lambrou, V. Lambadiari, 2018, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Eligibility and Awareness Regarding Metabolic Surgery in Patients With Type 2 Diabetes Mellitus in the Real-World Clinical Setting; Estimate of Possible Diabetes Remission

C. Koliaki, A. Thanopoulou, N. Tentolouris, 2020, Frontiers in Endocrinology.

Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes

V. Lambadiari, I. Ikonomidis, L. Palaiodimou, 2020, American journal of physiology. Endocrinology and metabolism.

Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center

S. Liatis, G. Dimitriadis, V. Lambadiari, 2023, International journal of molecular sciences.

Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function

V. Lambadiari, I. Ikonomidis, G. Pavlidis, 2024, Medicina.

Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease

G. Siasos, E. Oikonomou, A. Tsapas, 2024, Journal of the Endocrine Society.